---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-015884"
form_type: "8-K"
ticker: "MTVA"
cik: "0001638287"
company_name: "MetaVia Inc."
filed_at: "2023-09-19T23:59:59+00:00"
generated_at: "2026-06-10T13:30:32.430051+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# NeuroBo board member Na Yeon (Irene) Kim resigns effective immediately

## Summary
- Na Yeon (Irene) Kim resigned from the Board of Directors on September 18, 2023.
- Resignation effective immediately; no reason of disagreement with company operations, policies, or practices.
- No replacement announced; remaining board composition unchanged.

## SEC filing metadata
- accession: 0001558370-23-015884
- form_type: 8-K
- ticker: MTVA
- cik: 0001638287
- company_name: MetaVia Inc.
- filed_at: 2023-09-19T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1638287/000155837023015884/0001558370-23-015884-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1638287/000155837023015884/nrbo-20230918x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-015884
- JSON: https://secwatch.observer/filing/0001558370-23-015884.json
- Plain text: https://secwatch.observer/filing/0001558370-23-015884.txt

## Key facts
- Executive change
  Na Yeon (Irene) Kim resigned as Director at MetaVia Inc..
  - Action: resigned
  - Role: Director
  source text: On September 18, 2023, Ms. Na Yeon (Irene) Kim provided notice of her resignation from the Board of Directors (the “Board”) of NeuroBo Pharmaceuticals, Inc. (the “Company”), effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1638287/000155837023015884/0001558370-23-015884-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.